Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Prescient Therapeutics.
RELATED STOCKHEAD STORIES
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Health & Biotech
Prescient equips CAR-T cells with cancer-fighting binders in manufacturing milestone
Health & Biotech
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention
Health & Biotech
Invion led a group of ASX cancer stocks up after promising news
Health & Biotech
Budget review: Here’s what ASX biotech players thought of the ‘patent box’
Health & Biotech
Prescient strengthens ties with leading CAR-T research centre
News
Quarterlies Top 6: Who got a standing ovation today?
Prescient Therapeutics bone marrow cancer trial progresses
News
Market highlights and 5 ASX small caps to watch on Friday
Health & Biotech
Blood cancer is becoming a big killer but there are only a handful of ASX stocks fighting it
Health & Biotech
Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
Health & Biotech
How CAR T cancer treatment saved Laurie Adami’s life
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
